Insilico Medicine Hong Kong Limited

This early-stage trial tests a new drug, ISM5939, in about 159 adults with advanced or metastatic solid tumors that have not responded to standard treatments. The study has three parts: first, finding a safe dose of ISM5939 alone; second, fine-tuning the dose; and third, testing …

This early-stage study tests whether a new oral drug called ISM8969 is safe and how the body processes it. About 100 healthy adults, elderly people, and obese adults at risk for heart disease will receive either the drug or a placebo. The goal is to check for side effects and mea…